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EDITORIAL
Lessons from the recent Journal Citation Report ﬁgures
Mid-June has always been a period of great hope or
perhaps fear for editors of medical journals. This is the
time of the year when new ﬁgures for impact factors
are released from the ISI Web of Knowledge. How-
ever, most editors these days have a good insight into
the development of this very much debated instru-
ment for evaluation of a journal’s relative importance
for the distribution of scientiﬁc information. By con-
sultations of the continuous updating of citation ﬁg-
ures for each individual article of their journals in
either Web of Science (Thompson & Reuter) or
SCOPUS (Elsevier) it is possible to make fairly
good estimates of the ﬁgures to come. It was therefore
not a great surprise to us when the new impact factor
ﬁgure this time had increased to a record high 0.733.
This also means that we have now increased our
impact ﬁgure for ﬁve consecutive years (Figure 1).
Unfortunately, we are afraid that there will be a dip
next year, since the direct link to our home page at
PubMed has been insufﬁcient for almost a year. That
has now been corrected in parallel with the connec-
tion of our journal to PubMed Central. This is an
instrument for everyone to have free electronic access
to all articles, in the case of UJMS from 1973 and
onwards. Hopefully, this will mean that our ﬁgure for
‘total cites per year’ will increase from this year’s 259,
which was almost identical to that of last year (262).
The ﬁgures of this year’s Journal Citation Report
reveal that our ‘Immediacy index’ (a measure of
how often an article is cited during the publication
year) has increased (from 0.067 to 0.083) and that
ﬁgures for ‘Cited half-life’ (the median age of an
UJMS article cited in 2009) and ‘Citing half-
life’ (the median age of the items that UJMS cited
in its 2009 articles) are well below 10 years.
As mentioned above, an alternative database for
information on the performance of medical journals
is that of SCOPUS. Their SJR and SNIP ﬁgures are at
present somewhat too unknown and vague to com-
ment upon,buttheirﬁguresforpercentageofnotcited
papers in different journals are quite straight forward.
In Figure 2 we have gathered data on percentages of
articles not cited for UJMS and three other journals of
interest—New England Journal of Medicine (the
‘dragon’), Acta Dermato-Venereologica (another
Uppsala-based journal), and The Lancet. At least
two major conclusions can be drawn: 1) Also in the
‘ﬁnest’ journals there are substantial numbers of
papers that are not cited at all in the ﬁrst 3–5 years
after publication; and 2) the percentage of articles in
our own journal that indeed have been cited is as high
as for papers in the journals chosen for comparison. So
the possibility of being cited seems as good in our
journal as in any other more highly ranked journals.
Perhaps one would dare to say that it is more impor-
tant what is in the article than where it is published, at
least when it comes to raw citation ﬁgures.
Another way of judging the success of a scientiﬁc
journal and its articles was recently published by the
Swedish Research Council in a publication named
‘Swedish production of highly cited scientiﬁc pub-
lications’ (Vetenskapsrådets Lilla Rapportserie, 1: 2010).
Of special interest in that article is the methodological
deﬁnition of what is the ‘most highly cited pub-
lications’ in the world. In order to belong to the
10% most cited papers an article has to be cited at
least seven times during the publication year and the
2 years to come (self-citations not included). For the
next level, the 1% most cited publications, the ﬁgure
is 21 citations. It is obviously in the interest of the
editor of a scientiﬁc journal to accept/gather as many
articles of this kind as possible. The Research Council
report has used ﬁgures of this kind to describe/
compare the scientiﬁc success of different nations
and universities. We are happy to ﬁnd that in
UJMS, amongst the publications of the last 9 years/
volumes, there was one article (Nielsen et al., 2005,
vol. 110, pp. 179–183) that had nine citations. Inter-
estingly, that paper deals with a subject of great
interest in Sweden these days—low-carbohydrate
diet in type 2 diabetes. This ﬁeld of research has
been claimed to lack scientiﬁc contributions of high
quality (Mat vid diabetes—SBU rapport: 2010). It is
good to see that at least our journal has got one such
article. There might be more to come. Thus, in our
volume of 2008, with half a year more to go, one
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another article from our journal will be classiﬁed as a
‘highly cited publication’ (data from SCOPUS).
Some ﬁnal comments will deal with the experience
from the collaboration with our new publisher,
Informa Healthcare, and the use of the ScholarOne
Manuscript Central. All in all it has been a pleasant
and smooth one, with the insufﬁciency of the PubMed
link as the only complication. As with other journals
introducing the manuscript central there has been a
marked increase of the manuscript inﬂow. At present
we handle some 150 papers on an annual basis. This
means that more than two-thirds of them have to be
rejected, since we cannot lodge more than about
40 manuscripts per volume. Still, we recommend it
to our colleagues in Uppsala, juniors and seniors, to
submit their papers to UJMS. In last year’s four issues
less than 40% of the contributions were from Uppsala
or had Uppsala collaborators. We think that this ﬁgure
could be increased to a certain extent. We can offer
short handling times (last year 26 days) with early
online publication of accepted papers and also open-
access facilities, which by the way will become man-
datory for recipients of VR and EU grants in the near
future. In doing so we should be able to have in hand
at our premises a highly reputed medical journal that
can serve as a quick and convenient publisher of
acknowledgeable science.
Arne Andersson
Editor, basic sciences
Gunnar Ronquist
Editor, clinical sciences
2004
0
20
40
%
 
a
r
t
i
c
l
e
s
 
n
o
t
 
c
i
t
e
d
60
80
100
Percentage not cited
2005 2006 2007 2008 2009
Figure 2. A graph from SCOPUS journal analyser showing the percentage of articles in that year that have never been cited as of 9 April 2010.
Upsala Journal of Medical Sciences (diamonds), New England Journal of Medicine (triangles), The Lancet (circles), and Acta Dermato-
Venereologica (crosses).
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Figure 1. A graph imported from ISI Web of Knowledge demonstrating the impact factor trend for Upsala Journal of Medical Sciences. The
previous all-time high, 0.688, was from the year 2002.
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